Biote Corp (BTMD)

• Market cap: $114M
• 1 day: 9.01%
• 5 days: -4.47%
• 1 month: -14.39%
• 3 months: -39.80%
• 6 months: -33.76%
• Year to date: -39.80%
• 1 year: -36.54%
• 5 years: -42.47%
• 10 years: -42.47%
• Sector: Healthcare
• Industry: Medicinal Chemicals & Botanical Products

About: Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.

Employees: 217

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

77% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 13

68% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 19

16% more capital invested

Capital invested by funds: $99.7M [Q3] → $116M (+$16.3M) [Q4]

12% more funds holding

Funds holding: 83 [Q3] → 93 (+10) [Q4]

2.64% more ownership

Funds ownership: 54.84% [Q3] → 57.48% (+2.64%) [Q4]

0% more funds holding in top 10

Funds holding in top 10: 2 [Q3] → 2 (+0) [Q4]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $8 120% upside
• Avg. target: $8 120% upside
• High target: $8 120% upside

1 analyst rating

• positive: 1 100%
• neutral: 0 0%
• negative: 0 0%

Craig-Hallum Alex Fuhrman 50% 1-year accuracy 5 / 10 met price target

120% upside $8

Buy Maintained

13 Mar 2025